Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Youngsu You, Hee Sun Kim, Jung Woo Park, Gyochang Keum, Sung Key Jang & B. Moon Kim. (2018)
Sulfur(
vi
) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies
. RSC Advances 8:55, pages 31803-31821.
Crossref
Crossref
Qi-Fei Zhong, Rui Liu & Gang Liu. (2015) Structure–activity relationship studies on quinoxalin-2(1H)-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870. Molecular Diversity 19:4, pages 829-853.
Crossref
Crossref
Il Hak Bae, Hee Sun Kim, Youngsu You, Chieyeon Chough, Weonu Choe, Min Kyung Seon, Seung Gi Lee, Gyochang Keum, Sung Key Jang & B. Moon Kim. (2015) Novel benzidine and diaminofluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors. European Journal of Medicinal Chemistry 101, pages 163-178.
Crossref
Crossref
Eva Rivero-Buceta, Paula Carrero, Elisa G. Doyagüez, Andrés Madrona, Ernesto Quesada, María José Camarasa, María Jesús Peréz-Pérez, Pieter Leyssen, Jan Paeshuyse, Jan Balzarini, Johan Neyts & Ana San-Félix. (2015) Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors. European Journal of Medicinal Chemistry 92, pages 656-671.
Crossref
Crossref
Leonard B. Seeff. (2015) Drug-Induced Liver Injury Is a Major Risk for New Drugs. Digestive Diseases 33:4, pages 458-463.
Crossref
Crossref
Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T. Røge, Suzanne Lunding, Toke S. Barfod, Lone G. Madsen, Britta Tarp, Peer B. Christensen, Jan Gerstoft, Alex L. Laursen, Jens Bukh & Nina Weis. (2014) Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations. PLoS ONE 9:12, pages e113034.
Crossref
Crossref
Ramesh Kakarla, Jian Liu, Devan Naduthambi, Wonsuk Chang, Ralph T. Mosley, Donghui Bao, Holly M. Micolochick Steuer, Meg Keilman, Shalini Bansal, Angela M. Lam, William Seibel, Sandra Neilson, Phillip A. Furman & Michael J. Sofia. (2014) Discovery of a Novel Class of Potent HCV NS4B Inhibitors: SAR Studies on Piperazinone Derivatives. Journal of Medicinal Chemistry 57:5, pages 2136-2160.
Crossref
Crossref
John F. Miller, Pek Y. Chong, J. Brad Shotwell, John G. Catalano, Vincent W.-F. Tai, Jing Fang, Anna L. Banka, Christopher D. Roberts, Michael Youngman, Huichang Zhang, Zhiping Xiong, Amanda Mathis, Jeffery J. Pouliot, Robert K. Hamatake, Daniel J. Price, John W. SealIIIIII, Lisa L. Stroup, Katrina L. Creech, Luz H. Carballo, Dan Todd, Andrew Spaltenstein, Sylvia Furst, Zhi Hong & Andrew J. Peat. (2013) Hepatitis C Replication Inhibitors That Target the Viral NS4B Protein. Journal of Medicinal Chemistry 57:5, pages 2107-2120.
Crossref
Crossref
Daniele Serranti, Giuseppe Indolfi & Massimo Resti. (2014) New treatments for chronic hepatitis C: An overview for paediatricians. World Journal of Gastroenterology 20:43, pages 15965.
Crossref
Crossref
Joel P. Wedd & Scott W. Biggins. 2014. Hepatitis C Virus and Liver Transplantation. Hepatitis C Virus and Liver Transplantation
95
106
.
Klaas Poelstra, Leonie Beljaars & Barbro N. Melgert. (2013) Cell-specific delivery of biologicals: problems, pitfalls and possibilities of antifibrotic compounds in the liver. Drug Discovery Today 18:23-24, pages 1237-1242.
Crossref
Crossref
Siew Pheng Lim, Qing-Yin Wang, Christian G. Noble, Yen-Liang Chen, Hongping Dong, Bin Zou, Fumiaki Yokokawa, Shahul Nilar, Paul Smith, David Beer, Julien Lescar & Pei-Yong Shi. (2013) Ten years of dengue drug discovery: Progress and prospects. Antiviral Research 100:2, pages 500-519.
Crossref
Crossref
Yanping Li, Zonggen Peng, Lanhu Hao, Zhouyi Wu, Yanping Zhu, Laixing Hu, Jiandong Jiang & Zhuorong Li. (2013) Synthesis of novel substituted N-aryl benzamides as hA3G stabilizers and their inhibitory activities against hepatitis C virus replication. Acta Pharmaceutica Sinica B 3:5, pages 312-321.
Crossref
Crossref
A.K. Le Page, P. Robertson & W.D. Rawlinson. (2013) Discordant hepatitis C serological testing in Australia and the implications for organ transplant programs. Journal of Clinical Virology 57:1, pages 19-23.
Crossref
Crossref
Bryan Cobb, Paul J Pockros, Regis A Vilchez & John M Vierling. (2013) HCV RNA Viral Load Assessments in the Era of Direct-Acting Antivirals. American Journal of Gastroenterology 108:4, pages 471-475.
Crossref
Crossref
Christian M. Lange & Stefan Zeuzem. (2013) Perspectives and challenges of interferon-free therapy for chronic hepatitis C. Journal of Hepatology 58:3, pages 583-592.
Crossref
Crossref
James R. BurtonJr.Jr. & Gregory T. Everson. (2013) Management of the Transplant Recipient with Chronic Hepatitis C. Clinics in Liver Disease 17:1, pages 73-91.
Crossref
Crossref
Catherine AM Stedman. (2013) Current prospects for interferon-free treatment of hepatitis C in 2012. Journal of Gastroenterology and Hepatology 28:1, pages 38-45.
Crossref
Crossref
Christopher R. BolenMichael D. RobekLeonid BrodskyVincent SchulzJoseph K. LimMilton W. TaylorSteven H. Kleinstein. (2013) The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response. Journal of Interferon & Cytokine Research 33:1, pages 15-23.
Crossref
Crossref
Huang-Kai Peng, Wei-Chun Chen, Jin-Ching Lee, Shiang-Yu Yang, Cherng-Chyi Tzeng, Ying-Ting Lin & Shyh-Chyun Yang. (2013) Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses. Organic & Biomolecular Chemistry 11:11, pages 1858.
Crossref
Crossref
Mei H. Chang, Lori A. Gordon & Horatio B. Fung. (2012) Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C. Clinical Therapeutics 34:10, pages 2021-2038.
Crossref
Crossref
J. Brad Shotwell, Subramanian Baskaran, Pek Chong, Katrina L. Creech, Renae M. Crosby, Hamilton Dickson, Jing Fang, Dulce Garrido, Amanda Mathis, Jack Maung, Derek J. Parks, Jeffrey J. Pouliot, Daniel J. Price, Roopa Rai, John W. SealIIIIII, Uli Schmitz, Vincent W. F. Tai, Michael Thomson, Mi Xie, Zhiping Z. Xiong & Andrew J. Peat. (2012)
Imidazo[1,2-
a
]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization
. ACS Medicinal Chemistry Letters 3:7, pages 565-569.
Crossref
Crossref
Wonsuk Chang, Ralph T. Mosley, Shalini Bansal, Meg Keilman, Angela M. Lam, Phillip A. Furman, Michael J. Otto & Michael J. Sofia. (2012) Inhibition of hepatitis C virus NS5A by fluoro-olefin based γ-turn mimetics. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2938-2942.
Crossref
Crossref